Summary
Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Spanish pharmaceuticals market had total revenues of $25.4bn in 2020, representing a compound annual growth rate (CAGR) of 3.1% between 2016 and 2020.
- As part of reforms to Spain’s national healthcare system due to be undertaken by the Ministry of Health in 2021, the pharmaceutical market is expected to receive significant investment to accelerate research and technological development efforts. This could help to maintain growth in the sector.
- However, the growing popularity of cheaper, generic medicines in Spain, alongside the promotion of this substitute as part of new health reforms, is likely to limit overall market growth.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Spain
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Spain pharmaceuticals market by value in 2020?
- What will be the size of the Spain pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Spain pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Spain's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any other notable players in the market?
7.6. What has been the rationale behind recent collaborations?
7.7. Are there any threats towards leading players?
8 Company Profiles
8.1. Almirall S.A.
8.2. GlaxoSmithKline Plc
8.3. AstraZeneca PLC
8.4. Laboratorios Farmaceuticos ROVI, S.A.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Spain pharmaceuticals market value: $ billion, 2016-20
Table 2: Spain pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Spain pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Spain pharmaceuticals market share: % share, by value, 2020
Table 5: Almirall S.A.: key facts
Table 6: Almirall S.A.: Annual Financial Ratios
Table 7: Almirall S.A.: Key Employees
Table 8: GlaxoSmithKline Plc: key facts
Table 9: GlaxoSmithKline Plc: Annual Financial Ratios
Table 10: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 11: GlaxoSmithKline Plc: Key Employees
Table 12: GlaxoSmithKline Plc: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: Laboratorios Farmaceuticos ROVI, S.A.: key facts
Table 17: Laboratorios Farmaceuticos ROVI, S.A.: Annual Financial Ratios
Table 18: Laboratorios Farmaceuticos ROVI, S.A.: Key Employees
Table 19: Spain size of population (million), 2016-20
Table 20: Spain gdp (constant 2005 prices, $ billion), 2016-20
Table 21: Spain gdp (current prices, $ billion), 2016-20
Table 22: Spain inflation, 2016-20
Table 23: Spain consumer price index (absolute), 2016-20
Table 24: Spain exchange rate, 2016-20
List of Figures
Figure 1: Spain pharmaceuticals market value: $ billion, 2016-20
Figure 2: Spain pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Spain pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Spain, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Spain, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Spain, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2020
Figure 10: Spain pharmaceuticals market share: % share, by value, 2020
